Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X8QP
|
||||
Former ID |
DIB001247
|
||||
Drug Name |
FOSOPAMINE
|
||||
Synonyms |
S-2055; SIM-2055; Fosopamine < Rec INN >; N-Methyldopamine 4-O-phosphate; 4-[2-(Methylamino)ethyl]-1,2-benzenediol 1-(dihydrogen phosphate)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Discontinued in Phase 2 | [545255] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H14NO5P
|
||||
Canonical SMILES |
CNCCc1ccc(OP(=O)(O)O)c(O)c1
|
||||
InChI |
1S/C9H14NO5P/c1-10-5-4-7-2-3-9(8(11)6-7)15-16(12,13)14/h2-3,6,10-11H,4-5H2,1H3,(H2,12,13,14)
|
||||
InChIKey |
WHEGQKBWPSOMHG-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 103878-96-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Modulator | [530448], [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.